Moderna (MRNA)

Investing Cash Flow

$905.00M

TTM · Period ending: · USD

MRNA logo

MRNA Investing Cash Flow

Latest reported$905.00M
MRNA TTM Cash from Investing ($416.10M → $905.00M)
High-resolution chart · PNG

MRNA investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Moderna Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
905,000,000
1,140,000,000
1,946,000,000
1,455,000,000
1,476,000,000
2,561,000,000
1,949,000,000
1,950,000,000
2,018,000,000
2,313,000,000
4,206,000,000
3,696,000,000
3,852,000,000
756,000,000
-5,176,000,000
-5,266,000,000
-9,538,000,000
-12,264,000,000
-8,523,000,000
-7,575,129,000
-5,426,389,000
-1,535,389,000
-1,671,407,000
-1,350,930,000
-59,303,000
-319,204,000
-14,945,000
-138,884,000
-135,783,000
99,473,000
-372,472,000
-266,082,000
-367,776,000
-211,870,000
416,095,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.